ASH Clinical News FINAL_ACN_3.14_FULL_ISSUE_DIGITAL | Page 52

Written in Blood DLBCL patient population. Also, the trial was designed at a time when the interval between R-CHOP cycles was uncertain. “Although we did not ob- serve increased toxicity with a two-week interval schedule (R-CHOP 14), a three-week delivery (R-CHOP 21)